Published: May 30, 2026
Written by Klarity Editorial Team
Published: May 30, 2026

If you’re struggling with Binge Eating Disorder (BED), you might be wondering whether you can access treatment through telehealth—especially medications that can help manage symptoms. The short answer is yes, and the good news is that as of 2025-2026, telehealth access for BED medications like Topamax (topiramate) and Wellbutrin (bupropion) is fully legal, widely available, and regulated for your safety across the United States.
This guide will walk you through everything you need to know: what medications are available, how telehealth prescribing works, state-specific rules, who can prescribe for you, and how to ensure you’re getting safe, legitimate care.
Binge Eating Disorder is the most common eating disorder in the United States, characterized by recurrent episodes of eating large amounts of food in a short period (usually within two hours) while feeling a loss of control. Unlike bulimia, BED does not involve purging behaviors. To meet diagnostic criteria, these episodes must occur at least once weekly for three months and be accompanied by distress about the binge eating.
Treatment for BED typically involves a combination of approaches:
While the only FDA-approved medication specifically for BED is lisdexamfetamine (Vyvanse)—a controlled stimulant that requires stricter prescribing protocols—healthcare providers commonly and safely use off-label medications like Topamax and Wellbutrin to treat BED. These non-controlled medications have shown effectiveness in clinical studies and offer accessible treatment options through telehealth.
The biggest question patients have is: ‘Can my doctor legally prescribe medication without seeing me in person?’ For non-controlled medications like Topamax and Wellbutrin, the answer is definitively yes under federal law.
Here’s why: The Ryan Haight Act of 2008, which regulates telehealth prescribing, only applies to controlled substances (medications with abuse potential that are classified as Schedule II-V by the DEA). Topamax and Wellbutrin are not controlled substances—they’re regular prescription medications (called ‘legend drugs’). This means they were never subject to the federal in-person examination requirement that applies to medications like stimulants or opioids.
During the COVID-19 pandemic, the DEA created temporary flexibilities allowing controlled substances to be prescribed via telehealth without an initial in-person visit. These flexibilities have been extended through December 31, 2026, giving providers more time while permanent rules are finalized. However, for your BED treatment with non-controlled medications, no such waiver is even necessary—telehealth prescribing has always been permitted under federal law as long as standard medical care is provided.
While federal law allows telehealth prescribing of non-controlled medications, each state has its own medical practice laws that can add requirements. The good news: most states have permanently adopted telehealth-friendly policies following the pandemic.
Here’s what varies by state:
In-Person Visit Requirements:
Prescription Monitoring Programs (PMPs):
Provider Types:The prescriber must be licensed in your state. This can include:
Independent Practice States (34+ states plus DC):In states like California, New York, New Hampshire, Michigan, and Wisconsin, Nurse Practitioners have full practice authority. This means an NP can evaluate you, diagnose BED, and prescribe medications completely independently—no physician oversight required. These states have recognized that experienced NPs provide safe, high-quality care, especially for mental health conditions.
Notably, Wisconsin and Michigan both joined this group in 2025, expanding patient access to mental health providers.
Collaborative Practice States:In states like Texas, Florida, Georgia, and Alabama, NPs and PAs must work under a collaborative agreement with a physician. This doesn’t usually affect your care experience—you’ll still see the NP or PA for your appointments, and they can prescribe your medications. The collaboration happens behind the scenes for clinical oversight and regulatory compliance.
What This Means for You:Whether your telehealth provider is an MD, DO, NP, or PA, as long as they’re licensed in your state and following their scope of practice rules, they can legally and safely prescribe Topamax or Wellbutrin for your BED treatment. The prescriber type doesn’t affect the quality of care you receive—what matters is their expertise in treating eating disorders and mental health conditions.
How it works: Originally approved for seizures and migraine prevention, topiramate affects neurotransmitters that may help reduce impulsive eating behaviors and food cravings.
Off-label use: While not FDA-approved specifically for BED, clinical studies have shown topiramate can reduce binge frequency and support weight management in some patients. Providers typically start with low doses (25-50mg) and gradually increase.
Important safety considerations:
Telehealth prescribing: Fully allowed in all states. Typical prescription is 30-90 day supply with refills.
How it works: Approved for depression and smoking cessation, bupropion affects dopamine and norepinephrine—neurotransmitters involved in reward pathways and impulse control. Some patients find it helps reduce binge urges.
Off-label use: Research suggests bupropion may help some people with BED, particularly those who also experience depression or have struggled with weight management.
Critical safety warnings:
Common side effects: Insomnia, dry mouth, headache, increased energy (which some find helpful), or anxiety.
Telehealth prescribing: Fully allowed nationwide. Typically prescribed as 30-90 day supply with refills.
A legitimate telehealth evaluation for BED should feel comprehensive, not rushed. Here’s what typically happens:
Before your appointment:
During the video visit (usually 30-45 minutes):
Red flags to watch for:
Starting medication:
Follow-up schedule:
What good telehealth providers do:
If you’re in a state with periodic in-person requirements (Alabama, Georgia, New Hampshire):
Documentation:
Most insurance plans now cover telehealth visits for mental health and eating disorder treatment at the same rate as in-person visits. This includes:
Medication coverage:
At Klarity Health, we’ve built our platform specifically to make mental health treatment—including eating disorder care—accessible and straightforward. Here’s what sets us apart:
Provider Availability:
Transparent Pricing:
Comprehensive Care:
Quality and Safety:
The telehealth industry has grown rapidly, and while this has expanded access to care, it’s important to choose providers wisely. Recent enforcement actions against unsafe telehealth companies have highlighted the importance of quality standards.
Comprehensive evaluations:
Regulatory compliance:
Appropriate prescribing:
Transparency:
Be cautious if:
While telehealth works well for many people with BED, certain situations require in-person care:
Medical contraindications:
Mental health concerns:
Practical limitations:
If any of these apply, your telehealth provider should recognize this during evaluation and help connect you with appropriate in-person resources.
Telehealth platforms must comply with HIPAA (Health Insurance Portability and Accountability Act), which protects your medical information. This means:
Before starting telehealth treatment, you’ll sign consent forms that explain:
Your telehealth provider must meet the same standard of care as in-person providers. This includes:
Telehealth has limitations for emergencies. Know that:
DEA Telehealth Extensions:The DEA has extended pandemic-era flexibilities for controlled substance prescribing through December 31, 2026. While this doesn’t directly affect non-controlled BED medications, it signals continued federal support for telehealth access.
A permanent DEA rule on telehealth prescribing is expected by the end of 2026. The proposed rule had included requirements like special DEA registration for telehealth prescribers, but these are still being finalized and will primarily affect controlled substances, not the medications discussed here.
Several states expanded telehealth access and provider scope in 2025:
New Hampshire: Passed legislation explicitly allowing controlled substance prescribing via telehealth (with annual in-person follow-up), removing previous barriers.
Wisconsin and Michigan: Granted full practice authority to Nurse Practitioners, meaning NPs can now evaluate and treat patients independently—expanding the pool of available providers.
Delaware: Clarified that telehealth can be used for medication-assisted treatment of opioid use disorder, resolving previous legal ambiguities.
California: Further refined their ‘good faith exam’ definition to explicitly include asynchronous telehealth, expanding flexibility.
The trend is clear: telehealth is becoming a permanent, well-regulated part of healthcare. As of 2026, you can expect:
The focus from regulators has been on preventing abuse while maintaining patient access—especially for mental health and chronic conditions like eating disorders where telehealth has proven particularly valuable.
If you’re ready to explore telehealth treatment for Binge Eating Disorder, here are your next steps:
1. Assess your readiness:
2. Choose a reputable provider:
3. Prepare for your first appointment:
4. Set realistic expectations:
5. Commit to the process:
If you’re struggling with Binge Eating Disorder, know that effective, legal, and safe treatment is available through telehealth in 2025-2026. Medications like Topamax and Wellbutrin can be prescribed via video visits in all 50 states, often without ever needing an in-person appointment.
The regulatory framework has matured significantly since the pandemic, creating clear rules that protect patients while ensuring access. Whether you’re in a state with full NP independence or one requiring physician collaboration, whether you need to schedule a periodic in-person check or can continue fully remote—licensed, qualified providers are available to help.
At Klarity Health, we’re committed to making this process as straightforward and supportive as possible. With transparent pricing, provider availability across multiple states, acceptance of both insurance and self-pay, and a focus on comprehensive, evidence-based care, we’re here to help you take the next step in your recovery journey.
Remember: Binge Eating Disorder is a recognized medical condition, not a personal failing. You deserve compassionate, expert care—and you don’t have to do it alone. Whether through telehealth or in-person services, help is available, accessible, and effective.
Ready to get started? Reach out to schedule an evaluation and explore whether telehealth BED treatment is right for you. Your path to recovery can begin today.
Verified as of: January 4, 2026
This guide is based on the most current federal and state regulations governing telehealth prescribing as of early 2026. Key verification points include:
DEA Telehealth Rules: COVID-19 telehealth prescribing flexibilities for controlled substances remain in effect through December 31, 2026 (fourth extension). Non-controlled medications like Topamax and Wellbutrin were never subject to Ryan Haight Act restrictions and continue to be fully prescribable via telehealth.
State Regulations: Laws and medical board rules from 10+ states were verified using 2025 sources. Over 80% of citations are from 2025 or were updated/confirmed in 2025.
Pending Changes: Alabama and South Carolina NP scope legislation was proposed in 2025 but final status remains unclear—both states currently require physician collaboration for NPs. The DEA’s final rule on permanent telehealth prescribing standards is expected by end of 2026.
U.S. Department of Health and Human Services (HHS). ‘DEA Extends Telemedicine Prescribing Flexibilities Through December 31, 2026.’ Press Release, January 2, 2026. Available at: https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
Sheppard Mullin Richter & Hampton LLP. ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Healthcare Law Blog, August 2025. Available at: https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/
Center for Connected Health Policy (CCHP). ‘State Telehealth Laws & Reimbursement Policies: Online Prescribing.’ Updated November-December 2025. Available at: https://www.cchpca.org/topic/online-prescribing/
Health Jobs Nationwide. ‘State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025).’ Blog post, 2025. Available at: https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/
DailyMed (National Library of Medicine). ‘Bupropion Hydrochloride Extended-Release Tablets – FDA Label.’ Latest revision. Available at: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1b69c253-4740-44b0-be63-6c20834540b6&type=display
Note: State telehealth laws and provider scope regulations continue to evolve. Patients should verify current rules in their specific state, and providers must ensure compliance with their state’s medical board requirements. This guide provides general information and should not replace personalized medical advice.
Find the right provider for your needs — select your state to find expert care near you.